China's Shanghai Pharmaceuticals Holding has agreed to buy the Chinese business of NYSE-listed Cardinal Health for $557 million in cash, potentially making it the largest distributor of imported drugs in the country.
¬ Haymarket Media Limited. All rights reserved.
